Oncology Institute Inc (The)

Oncology Institute Inc (The)

TOI - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$652.89M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Oncology Institute Inc (The)Oncology Institute Inc (The)-21.8-146%1-4.3
$9.50

Target Price by Analysts

85.2% upsideOncology Institute(The) Target Price DetailsTarget Price
$-4.71

Current Fair Value

191.8% downside

Overvalued by 191.8% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$652.89 Million
Enterprise Value$718.43 Million
Earnings per Share$-0.54
Beta0.42
Outstanding Shares103,031,493

Return

Return on Equity145.67%ROE
Return on Assets-20.36%
Return on Invested Capital-35.30%

Valuation & Multiples

P/E Ratio-21.77P/E Ratio
PEG51.28PEG
Price to Sales1.03Price to Sales
Price to Book Ratio-5.13Price to Book Ratio
Enterprise Value to Revenue1.22
Enterprise Value to EBIT-24.43
Enterprise Value to Net Income-20
Total Debt to Enterprise0.15
Debt to Equity-4.28Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
August 12, 2026
EPS Estimate
$-0.07
Consensus analyst estimate
Revenue Estimate
$155.21 M
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.08, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.0755▲ 1.02%
Total Calls2,744,600▲ 13.14%
Total Puts207,200▲ 30.89%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %3.91%▲ 0.11%
Total Invested$218.83M▲ 84.00%
Investors Holding128▲ 8.00%

About DFP Healthcare Acquisitions Corp

641 employees
CEO: Daniel Virnich

DFP Healthcare Acquisitions Corp. is a blank check company. The Company’s business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more ...

Oncology Institute(The) Insider Information FAQ

Stockcircle tracks 3 top investors with a current 13F position in Oncology Institute(The). Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 2 top investors increased or opened positions and 1 top investor reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Stockcircle shows 7 open-market insider purchases and 2 open-market insider sales for Oncology Institute(The) in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.